Related Experiment Videos
Cervical cancer screening in Italy
1CPO Piemonte-Unit of Cancer Epidemiology, Via San Francesco da Paola, 31-10123, Torino, Italy.
Summary
Italy is transitioning to organized cervical cancer screening programs, aiming for better coverage and standardized Pap-tests. Early results show promise, with potential reductions in cervical cancer incidence.
Area of Science:
- Public Health
- Oncology
- Epidemiology
Background:
- Cervical cancer screening in Italy was historically opportunistic, leading to low coverage and frequent testing.
- A shift towards organized, nationwide screening programs began in 1996, with guidelines recommending Pap-tests every three years for women aged 25-64.
Purpose of the Study:
- To evaluate the implementation and early impact of newly established organized cervical cancer screening programs in Italy.
- To assess adherence to national and European guidelines regarding screening protocols, diagnostic work-up, and quality assurance.
Main Methods:
- Analysis of data from organized screening programs collected through the Italian Group for Cervical Cancer Screening (GISCi).
- Monitoring of screening coverage, referral systems, laboratory capacity, and cytology interpretation standardization.
- Comparison of screening activities and preliminary outcomes across different regions and programs.
Main Results:
- By 1999, 34% of the target population was included in organized programs, with documented improvements in coverage in some areas.
- Most programs implemented fail-safe systems and diagnostic protocols, but laboratory sizes were often suboptimal.
- Quality assurance for cytology interpretation varied, with no nationwide standardization, indicating heterogeneity in interpretation criteria.
Conclusions:
- Organized cervical cancer screening programs in Italy are expanding, showing positive impacts on coverage.
- Standardization of cytology interpretation and laboratory capacity are key areas for improvement.
- Preliminary data suggest a potential reduction in cervical cancer incidence, particularly in established programs, warranting future observation.